Anti-GFAP Antibody anti-GFAP - Poly28400,BioLegend,840001

Multiple protein fragments ranging from 38 to 48 kD have been reported in human CNS lysates resulting from caspase- and calpain-mediated cleavage of GFAP.

Host

Rabbit

Reactivity

Human, Mouse, Rat

Application

WB -Quality testedIHC-P -Verified

Platform ID

BAB465710818

BioLegend

Headquarters

8999 BioLegend Way San Diego, CA 92121 United States

Contact

Tel: 1-858-455-9588
Fax: +49 (4131) 7023913

Email:

Product Specifications
Scientific Background

Specifications

NameAnti-GFAP Antibody anti-GFAP - Poly28400
Cat. No.840001
HostRabbit
RRIDAB_2565444 (BioLegend Cat. No. 840001)
IsotypeRabbit Polyclonal IgG
ReactivityHuman, Mouse, Rat
ApplicationWB -Quality testedIHC-P -Verified
ClonalityPolyclonal
Clone NumberPoly28400
TargetGFAP
ImmunogenThis antiserum was made with a preparation of recombinant GFAP expressed in bacteria and highly purified. Subsequent boosts were performed with purified GFAP from bovine spinal cord.
PuritySerum
StorageStore at -20°C. Upon initial thawing, apportion into working aliquots and store at -20°C. Avoid repeated freeze-thaw cycles to prevent denaturing the antibody. For long-term storage, keep the antibody at -80°C.
Regulatory StatusResearch Use Only

Scientific Background

Glial Fibrillary Acidic Protein (GFAP) was found to be a member of the 10nm or intermediate filament protein family, specifically the intermediate filament protein family Class III, which also includes peripherin, desmin and vimentin. The GFAP protein runs on gels at ~55kD protein, usually associated with lower molecule weight bands which are thought to be proteolytic fragments and alternate transcripts from the single gene. GFAP is strongly and specifically expressed in astrocytes and certain other astroglia in the central nervous system, in satellite cells in peripheral ganglia, and in non-myelinating Schwann cells in peripheral nerves. In many damage and disease states GFAP expression is heavily upregulated in astrocytes. In addition neural stem cells frequently strongly express GFAP. Antibodies to GFAP are therefore very useful as markers of astrocytic cells and neural stem cells. In addition many types of brain tumor, presumably derived from astrocytic cells, heavily express GFAP. Finally, Alexander's disease was recently shown to be caused by point mutations in protein coding region of the GFAP gene. All forms of Alexander disease are characterized by the presence of Rosenthal fibers, which are GFAP containing cytoplasmic inclusions found in astrocytes.

Category Paths

Request a product

Please provide the required information below so that we can quickly source your products.